ArticleCureus2026
Red Cell Distribution Width-to-Platelet Count Ratio as an Early Marker of Severity in Acute Pancreatitis: A Diagnostic Accuracy Study at a Tertiary Care Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEarly identification of clinically significant acute pancreatitis is essential for timely escalation of care, yet established scoring systems are multiparametric, and several require 48-hour data. The red cell distribution width (RDW)-to-platelet count ratio is a composite index derived from the routine complete blood count that may reflect the systemic inflammatory burden of the disease. This study assessed its accuracy for identifying moderately severe or severe disease at admission.
methodsConsecutive adults admitted with acute pancreatitis were enrolled on accrual at a tertiary care center. The ratio was calculated from the admission RDW and platelet count. Disease severity was classified using the Revised Atlanta Classification; the target condition for the accuracy analysis was moderately severe or severe disease versus mild disease. Associations with the Ranson score, intensive care admission, organ failure, and length of hospital stay were examined, and discrimination was assessed using the area under the receiver operating characteristic curve.
resultsAmong 142 patients (mean age: 43 years; 86 (60.6%) men), 47 (33.1%) patients had moderately severe or severe disease. The ratio rose progressively across severity categories and was higher in patients requiring intensive care and those with organ failure (all p < 0.001). At a cut-off of 0.0601, it identified moderately severe or severe disease with sensitivity of 45/47 (95.7%), specificity of 74/95 (77.9%), and negative predictive value of 74/76 (97.4%) (area under the curve: 0.931).
conclusionsThe RDW-to-platelet ratio is a simple, inexpensive admission marker that showed high sensitivity and negative predictive value for clinically significant severity and may support early risk stratification, pending external validation alongside established assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.